{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T22:47:51Z","timestamp":1775170071096,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.cjca.2012.03.010","type":"journal-article","created":{"date-parts":[[2012,4,21]],"date-time":"2012-04-21T19:12:16Z","timestamp":1335035536000},"page":"318-325","source":"Crossref","is-referenced-by-count":46,"title":["Resistant Hypertension and Aldosterone: An Update"],"prefix":"10.1016","volume":"28","author":[{"suffix":"III","given":"Donald","family":"Clark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa I.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Calhoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2012.03.010_bib1","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"117","author":"Calhoun","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2012.03.010_bib2","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/HYPERTENSIONAHA.111.170308","article-title":"Prevalence of resistant hypertension in the United States, 2003-2008","volume":"57","author":"Persell","year":"2011","journal-title":"Hypertension"},{"issue":"5 pt 1","key":"10.1016\/j.cjca.2012.03.010_bib3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.amjhyper.2004.11.021","article-title":"Resistant hypertension revisited: a comparison of two university-based cohorts","volume":"18","author":"Garg","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cjca.2012.03.010_bib4","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/HYPERTENSIONAHA.110.168948","article-title":"Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring","volume":"57","author":"de la Sierra","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2012.03.010_bib5","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"Dahl\u00f6f","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2012.03.010_bib6","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1097\/HJH.0b013e32834a8a42","article-title":"Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk","volume":"29","author":"Gupta","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.cjca.2012.03.010_bib7","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cjca.2012.03.010_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.steroids.2005.09.017","article-title":"Nongenomic actions of aldosterone: physiological or pathophysiological role?","volume":"71","author":"Mihailidou","year":"2006","journal-title":"Steroids"},{"key":"10.1016\/j.cjca.2012.03.010_bib9","first-page":"1145","article-title":"Early nongenomic events in aldosterone action in renal collecting duct cells: PKCalpha activation, mineralocorticoid receptor phosphorylation, and cross-talk with the genomic response","volume":"15","author":"Le Mo\u00ebllic","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2012.03.010_bib10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/01.HYP.0000201443.63240.a7","article-title":"Effects of aldosterone on the vasculature","volume":"47","author":"Schiffrin","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2012.03.010_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/01.HYP.0000174329.99569.52","article-title":"Cardiovascular benefits of aldosterone receptor antagonists: what about potassium?","volume":"46","author":"Williams","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2012.03.010_bib12","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1097\/01.ASN.0000083982.74108.54","article-title":"Nongenomic vascular action of aldosterone in the glomerular microcirculation","volume":"14","author":"Arima","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2012.03.010_bib13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/01.HYP.0000111138.78714.1a","article-title":"Endothelium-derived nitric oxide modulates vascular action of aldosterone in renal arteriole","volume":"43","author":"Arima","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2012.03.010_bib14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/01.HYP.0000083298.23119.16","article-title":"Rapid nongenomic effects of aldosterone on human forearm vasculature","volume":"42","author":"Schmidt","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2012.03.010_bib15","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1161\/01.CIR.0000129307.26791.8E","article-title":"Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism","volume":"109","author":"Nishizaka","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2012.03.010_bib16","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2012.03.010_bib17","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","article-title":"Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats","volume":"63","author":"Blasi","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2012.03.010_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1210\/er.2005-0004","article-title":"The nongenomic actions of aldosterone","volume":"26","author":"Funder","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cjca.2012.03.010_bib19","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1053\/j.ajkd.2009.12.022","article-title":"Pathogenesis of hypertension: interactions among sodium, potassium, and aldosterone","volume":"55","author":"B\u00fcssemaker","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cjca.2012.03.010_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.03.010_bib21","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/HJH.0b013e32831286fd","article-title":"Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism","volume":"26","author":"Bernini","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.cjca.2012.03.010_bib22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1507\/endocrj.K09E-014","article-title":"Endothelial dysfunction is related to aldosterone excess and raised blood pressure","volume":"56","author":"Tsuchiya","year":"2009","journal-title":"Endocr J"},{"key":"10.1016\/j.cjca.2012.03.010_bib23","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.HYP.27.5.1039","article-title":"Changes in left ventricular anatomy and function in hypertension and primary aldosteronism","volume":"27","author":"Rossi","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2012.03.010_bib24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal damage in primary aldosteronism: results of the PAPY Study","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2012.03.010_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0272-6386(99)70298-2","article-title":"Cardiovascular complications in patients with primary aldosteronism","volume":"33","author":"Nishimura","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cjca.2012.03.010_bib26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF03347840","article-title":"Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension","volume":"18","author":"Takeda","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.cjca.2012.03.010_bib27","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2012.03.010_bib28","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/jama.205.7.497","article-title":"Incidence of primary aldosteronism uncomplicated \u201cessential\u201d hypertension","volume":"205","author":"Fishman","year":"1968","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2012.03.010_bib29","doi-asserted-by":"crossref","unstructured":"Kaplan NM. Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism. Ann Intern Med 967;66:1079-90.","DOI":"10.7326\/0003-4819-66-6-1079"},{"key":"10.1016\/j.cjca.2012.03.010_bib30","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/archinte.1987.00370070103015","article-title":"Secondary hypertension in a blood pressure clinic","volume":"147","author":"Sinclair","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2012.03.010_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11154-011-9162-8","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"12","author":"Rossi","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.cjca.2012.03.010_bib32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.cjca.2012.03.010_bib33","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2012.03.010_bib34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2012.03.010_bib35","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.jhh.1001554","article-title":"Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region","volume":"17","author":"Strauch","year":"2003","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.cjca.2012.03.010_bib36","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","article-title":"Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio","volume":"37","author":"Gallay","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cjca.2012.03.010_bib37","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2012.03.010_bib38","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1097\/00004872-200411000-00026","article-title":"Low-renin status in therapy-resistant hypertension: a clue to efficient treatment","volume":"22","author":"Eide","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.cjca.2012.03.010_bib39","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2337\/dc07-0031","article-title":"Primary aldosteronism in diabetic subjects with resistant hypertension","volume":"30","author":"Umpierrez","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cjca.2012.03.010_bib40","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1097\/00004872-200111000-00018","article-title":"High prevalence of cardiac and extracardiac target organ damage in refractory hypertension","volume":"19","author":"Cuspidi","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.cjca.2012.03.010_bib41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00126097-200310000-00001","article-title":"Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension","volume":"8","author":"Muxfeldt","year":"2003","journal-title":"Blood Press Monit"},{"key":"10.1016\/j.cjca.2012.03.010_bib42","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.amjhyper.2005.05.014","article-title":"Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension","volume":"18","author":"Pierdomenico","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cjca.2012.03.010_bib43","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2796.1994.tb00857.x","article-title":"Prognosis in therapy-resistant hypertension","volume":"236","author":"Isaksson","year":"1994","journal-title":"J Intern Med"},{"issue":"11 pt 1","key":"10.1016\/j.cjca.2012.03.010_bib44","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0895-7061(03)01032-X","article-title":"Efficacy of low-dose spironolactone in subjects with resistant hypertension","volume":"16","author":"Nishizaka","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cjca.2012.03.010_bib45","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","article-title":"Effect of spironolactone on blood pressure in subjects with resistant hypertension","volume":"49","author":"Chapman","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2012.03.010_bib46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/HYPERTENSIONAHA.109.140988","article-title":"Efficacy of spironolactone therapy in patients with true resistant hypertension","volume":"55","author":"de Souza","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2012.03.010_bib47","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1097\/HJH.0b013e32833d4c99","article-title":"Management of resistant arterial hypertension: role of spironolactone versus double blockade of the renin-angiotensin-aldosterone system","volume":"28","author":"Alvarez-Alvarez","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.cjca.2012.03.010_bib48","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/HYPERTENSIONAHA.109.141531","article-title":"Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study","volume":"55","author":"Gaddam","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2012.03.010_bib49","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jash.2008.05.005","article-title":"Effectiveness of the selective aldosterone blocker, eplerenone, in patients with resistant hypertension","volume":"2","author":"Calhoun","year":"2008","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.cjca.2012.03.010_bib50","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.HYP.0000179582.42830.1d","article-title":"Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension","volume":"46","author":"Saha","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2012.03.010_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/jhh.2011.60","article-title":"Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease","author":"Pisoni","year":"2011","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.cjca.2012.03.010_bib52","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.168.11.1159","article-title":"Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion","volume":"168","author":"Gaddam","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2012.03.010_bib53","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/clpt.1987.41","article-title":"The clinical pharmacology section of the International Union of Pharmacology","volume":"41","author":"Ogilvie","year":"1987","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cjca.2012.03.010_bib54","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.283.14.1829","article-title":"Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study","volume":"283","author":"Nieto","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2012.03.010_bib55","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200005113421901","article-title":"Prospective study of the association between sleep-disordered breathing and hypertension","volume":"342","author":"Peppard","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.03.010_bib56","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1097\/00004872-200112000-00022","article-title":"High prevalence of unrecognized sleep apnoea in drug-resistant hypertension","volume":"19","author":"Logan","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.cjca.2012.03.010_bib57","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1378\/chest.06-1442","article-title":"Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension","volume":"131","author":"Pratt-Ubunama","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2012.03.010_bib58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5664\/jcsm.27435","article-title":"Effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea","volume":"5","author":"Dernaika","year":"2009","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.cjca.2012.03.010_bib59","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1097\/HJH.0b013e32833b9c63","article-title":"Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial","volume":"28","author":"Lozano","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.cjca.2012.03.010_bib60","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5664\/jcsm.27878","article-title":"Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension","volume":"6","author":"Gonzaga","year":"2010","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.cjca.2012.03.010_bib61","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/HJH.0b013e3283492219","article-title":"Positive relationship of sleep apnea to hyperaldosteronism in an ethnically diverse population","volume":"29","author":"Sim","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.cjca.2012.03.010_bib62","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/HYPERTENSIONAHA.110.154427","article-title":"Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension","volume":"56","author":"Friedman","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2012.03.010_bib63","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/jhh.2009.96","article-title":"Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report","volume":"24","author":"Gaddam","year":"2010","journal-title":"J Hum Hypertens"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X12001705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X12001705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T07:45:34Z","timestamp":1594021534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X12001705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0828282X12001705"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2012.03.010","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}